Several pentacyclic triterpenoid metabolites of plant origin are inhibitors of hydrolysis of both synthetic peptide substrates and elastin by human leucocyte elastase (HLE). Ursolic acid, the most potent of these compounds, has an inhibition constant of 4-6 /tM for hydrolysis of peptide substrates in phosphate-buffered saline. With tripeptide and tetrapeptide substrates, the inhibition is purely competitive, whereas with a shorter dipeptide substrate the inhibition is noncompetitive, suggesting that ursolic acid interacts with subsite S3 of the extended substrate-binding domain in HLE, but not with subsites S, and S2. The carboxy group at position 28 in the pentacyclic-ring system of the triterpenes contributes to binding to HLE, since replacement of this group with a hydroxy group, as in uvaol, the alcohol analogue of ursolic acid, reduces the potency of inhibition. The inhibitory potency of ursolic acid is also reduced by addition of I M-NaCl, further supporting a postulated electrostatic interaction between the negative charge on the triterpene and a positively charged residue on the enzyme, which we assign to the side chain of Arg-217, located in the vicinity of subsites S4 and S5 in HLE. These observations are consistent with a binding site for ursolic acid which extends from S3 towards S4 and
INTRODUCTION
Human leucocyte elastase (HLE, EC 3.4.21.37 ) is a lysosomal proteinase stored in high quantities in the azurophilic granules of polymorphonuclear leucocytes (Dewald et al., 1975) . For decades the enzyme has been the subject of intensive study because of its potential for tissue destruction in many disease states, such as pulmonary emphysema and rheumatoid arthritis (Janoff, 1985) . Administration of exogenous elastase inhibitors has been proposed as a possible means of protecting tissues from proteolytic attack (Powers, 1983; Groutas, 1987) . A number of inhibitors have been isolated from natural sources or synthesized de novo (Groutas, 1987; Bode et al., 1989) ; some of these have been proved to be effective in animal models (Powers, 1983; Schnebli, 1985; Soskel et al., 1986) . In an effort to find naturally occurring substances which may be utilized as prototype compounds for synthetic inhibitors, we have identified several plant triterpenoids with considerable inhibitory activity towards HLE. Ursolic acid, a pentacyclic triterpene acid, has the greatest potency in this class of compounds. The present paper provides evidence that the inhibition of HLE by the triterpenes is due to reversible binding to a site which lies within a portion of the extended substratebinding domain of the enzyme.
MATERIALS AND METHODS Chemicals
Ursolic acid and other pentacyclic triterpenes, except uvaol, were from Carl Roth (Karlsruhe, Germany), and were all of h.p.l.c. standard grade. Uvaol was from Sigma (St. Louis, MO, U.S.A.). The structures of these triterpenes are given in Fig. 1 . Boc-Leu-ONp, MeO-Suc-Ala-Ala-Pro-Val-pNA, Suc-Ala-AlaAla-pNA and Suc-Ala-Ala-Pro-Phe-pNA were also from Sigma. Bz-Ile-Glu-Gly-Arg-pNA (S-2222) and pGlu-Pro-Val-pNA (S-2484) were from Kabi (Franklin, OH, U.S.A.). Elastin from bovine neck ligaments was from Elastin Products (Pacific, MO, U.S.A.) and was labelled with [14C] formaldehyde according to the procedure of Yu & Yoshida (1979) to a specific radioactivity of 160 nCi/mg. Dulbecco's modified phosphate-buffered saline [DPBS (per litre: KCI, 0.2 g; KH2PO4, 0.2 g; NaCl, 8 g; and Na2HP04,7H20, 2.171 g; pH 7.2 at 25°C; Hazleton Biologics, Lenexa, KS, U.S.A.)] was used as the buffer throughout the study.
Enzymes
HLE from azurophilic granules was from Athens Research and Technology (Athens, GA, U.S.A.). a-Chymotrypsin (EC 3.4.21.1) and tosylphenylalanylchloromethane ('TPCK')-treated trypsin (EC 3.4.21.4) were from Sigma. Porcine pancreatic elastase (EC 3.4.21.11) was from Elastin Products. The active centre of HLE was titrated with Z-Ala-Ala-Pro-azaAla-ONp (Enzyme Systems Products, Livermore, CA, U.S.A.) as described by Powers et al. (1984) .
Enzyme assays with synthetic substrates
The activity of HLE was routinely measured with substrate MeO-Suc-Ala-Ala-Pro-Val-pNA (Bieth et al., 1974) Other serine proteinases were assayed with the following substrates: a-chymotrypsin, Suc-Ala-Ala-Pro-Phe-pNA (Del- Mar et al., 1979) ; trypsin, Bz-Ile-Glu-Gly-Arg-pNA (Aurell et al., 1977) ; and porcine pancreatic elastase, Suc-Ala-Ala-AlapNA (Bieth et al., 1974) . The buffer used was 0.05 M-Tris/HCl containing 0.15 M-NaCl and I0O% DMSO, pH 8.0.
Enzyme assays with 14Clelastin
Elastolysis was determined by using a method modified from that of Yu & Yoshida (1979) . A volume of 100 ,ul of a 10 mg/ml suspension ofelastin prepared by diluting our stock of[14C]elastin with unlabelled protein to give a final specific radioactivity of 32 nCi/mg was added to a 1.5 ml microcentrifuge tube. The suspension was diluted with 800 ,u of DPBS and mixed with inhibitor in 50,1 of DMSO. Elastolysis was started by addition of 4.5 ,ug of HLE in 50 ,u of DPBS. The reaction was carried out with constant gentle agitation at 37 IC for 2 h, and quenched by addition of 400 ,d of 250% (w/v) trichloroacetic acid. After centrifugation, labelled peptides in supernatants were counted for radioactivity.
Kinetic analysis
Kinetic data were analysed by Dixon (1953) and, when appropriate, Cornish-Bowden (1974) plots, which were generated by non-linear least-squares regression of the raw velocity data and transformation of the best fits into the appropriate forms (Enzfitter; Elsevier-BIOSOFT, Cambridge, U.K.).
RESULTS

Inhibitory activity
Effects of ursolic acid on the amidolytic activity of HLE were first tested with MeO-Suc-Ala-Ala-Pro-Val-pNA as the substrate. Fig. 2 shows a Cornish-Bowden plot obtained for several different ursolic acid concentrations. Ursolic acid can be described as a competitive inhibitor, with a computed inhibition constant, K1, of 4 ,M. Interaction between ursolic acid and HLE appears to be rapid, since a linear rate of amidolysis had already been achieved within the instrumentation's 30 s dead time between mixing and commencement of data collection. Inhibition is reversible, as judged by partial recovery of amidolytic activity upon dilution of the enzyme-inhibitor mixture. More complete removal of the inhibitor by gel filtration on Sephadex G-25 resulted in full restoration of amidolytic activity. Since the inhibitor and the enzyme appear to form a reversibly dissociable complex which cannot progress further towards the catalytic step, the inhibition constant we have determined, 4,uM, can be considered as a true dissociation constant for ursolic acid from a binding site on HLE.
We next examined the inhibitory activity of ursolic acid using the insoluble substrate f14C]elastin. Fig. 3 The assays were performed in DPBS/5 % DMSO, pH 7.2, at 37 'C. The substrate concentration was 1 mg/ml, with a specific radioactivity of 32 nCi/mg. The enzyme concentration was 4.5 ,cg/ml. and two residues on the distal side, of the scissile peptide bond (Nakajima et al., 1979; Wei et al., 1988; Navia et al., 1989; reviewed by Bode et al., 1989 (Fig. 4) . This transformation points to the critical role of S3 for binding of ursolic acid to HLE. The simplest explanation for the results is that substrates which occupy S3 block ursolic acid from this binding site. The amino acid components of S3 have been identified to be Val-216 and Phe-192 (Wei et al., 1988; Navia et al., 1989; Bode et al., 1989) . It is likely that the binding site for ursolic acid and the S3 subsite for substrate binding share at least some common elements of these residues. We have considered the role of the carboxy group at position 28 of the ursolic ring system for binding to HLE. The activity of ursolic acid was assayed in the presence of high salt to probe the contribution of electrostatic interactions involving this group. Addition of up to 1 M-NaCl to the assay system does not change the mode of inhibition, but raises the value of K, from 4 ,uM to 13,CM. These results might be explained by a conformational distortion of the binding site caused by high salt. To exclude this possibility, we tested the inhibitory activity of uvaol, a pentacyclic triterpene alcohol with a structure identical with that of ursolic acid, except for a hydroxy group instead of a carboxylic group at position 28 (Fig. 1) . Uvaol is also a competitive inhibitor, with an inhibition constant, K1, of 16 /uM, a value comparable with that of ursolic acid in high salt solution (Table 2 ). These results demonstrate that electrostatic interactions between the 28-carboxy group and a positively charged group on the enzyme contribute to binding. At the pH employed in this study, arginine residues are the only positively charged amino acid residues in the enzyme (Sinha et al., 1987) . Their spatial distribution has been carefully determined by X-ray-crystallographic analysis Vol. 277 (Wei et al., 1988; Navia et al., 1989 (Wei et al., 1988; Navia et al., 1989; Bode et al., 1989) .
On the basis of the data described above, we propose that the binding site for ursolic acid extends from a C-terminal limit at S3, covers S4 and S,, and reaches to Arg-217 in the N-terminal direction. Binding of ursolic acid to this site should be responsible for the observed inhibition. Fig. 5 shows a diagrammatic representation of the binding. The conformer of ursolic acid is drawn by inference from the X-ray-crystallographic structure of hederagenin (Roques et al., 1978) , a closely related pentacyclic triterpene acid (Fig. 1) .
Specificity
The effect of ursolic acid on amidolysis catalysed by acchymotrypsin., trypsin and porcine pancreatic elastase was examined by using substrates Suc-Ala-Ala-Pro-Phe-pNA, BzIle-Glu-Gly-Arg-pNA and Suc-Ala-Ala-Ala-pNA respectively. With these chromogenic oligopeptide analogues as substrates, ursolic acid behaves as a simple competitive inhibitor of achymotrypsin, trypsin and pancreatic elastase, but with much lower potency than that seen with HLE. The inhibition constants were determined to be 37.0 +4.6 gtM for a-chymotrypsin (n = 3), 157 + 8 /SM for trypsin (n = 3), and 180 + 8 /,M for pancreatic elastase (n = 3). These results indicate that the specificity of inhibition by ursolic acid is not strictly restricted to HLE, and it can be expected that other serine proteinases might also be inhibited by this compound. Table 3 lists the inhibition constants of other pentacyclic triterpenes against HLE. The four compounds in Table 3 are members of the ,1-amyrin group of triterpenes, ursolic acid and uvaol belonging to the a-amyrin group. Since these triterpenes all have closely related structures (Fig. 1) , it is reasonable to assume that they are bound at the same site on HLE as ursolic acid. The contribution ofelectrostatic interactions to the overall free energy of binding of these inhibitors is apparent from comparison of the relative activities of oleanolic acid and erythrodiol, which differ only in the replacement of a carboxy group by a hydroxy group. The results in Table 3 show that oleanolic acid is a stronger inhibitor than erythrodiol, supporting the conclusion we have already drawn from comparison of the two corresponding aamyrins, ursolic acid and uvaol, that binding of triterpene acids to HLE is strengthened through formation of a salt bridge involving the carboxy group of the inhibitor.
Activity of other triterpenes
DISCUSSION
Ursolic acid can function either as a competitive inhibitor or as a non-competitive inhibitor of hydrolysis of peptide substrates by HLE, depending on the length of the substrate ( (Bode et al., 1989) . Aside from these interactions between subsites Si and S3, no other obvious conformational interactions can be deduced from the published X-ray-crystallographic data.
Some further understanding of the mechanism of inhibition of HLE by ursolic acid may be obtained by comparing the inhibition with that of the fatty acids. Cook & Ternai (1988) have recently proposed a binding site for oleic acid and related cis-unsaturated fatty acid analogues which lies within the extended substratebinding domain of HLE. They suggest that the double bond of oleic acid interacts with subsite S3, whereas the distal portion of the alkyl chain of the fatty acid extends to Si and the carboxy group is pointed towards the side chain of Arg-217. This putative binding site is very similar to the site we have described for ursolic acid, although we find no evidence for extension of the triterpenes towards S2 and Si on the enzyme. Regardless of the precise structural basis of the interactions of these inhibitors with HLE, the present data show that the extended substrate-binding domain of this proteinase has the ability to bind hydrophobic ligands with very different structures. The functional significance of the ability of HLE to accommodate a diversity of hydrophobic structures is uncertain, but it is well known that the enzyme is able to hydrolyse a broad spectrum of proteins, from the major components of the extracellular matrix to many plasma proteins (Bieth, 1989) . To bind and degrade various protein substrates, the extended substrate-binding domain should be able to accommodate molecules with different conformations. It seems reasonable to conclude that there is a common structural basis for the broad substrate specificity of HLE and its ability to bind a wide range of hydrophobic ligands which are not substrates, but which do affect substrate binding or catalysis. We implicate Arg-217 as playing a critical role in contributing to the free energy of binding of the negatively charged inhibitors to HLE, but the relative contributions of binding of such inhibitors to the S3 subsite and their electrostatic interactions with Arg-217 to the detailed molecular mechanism for inhibition remain to be elucidated.
Ursolic acid is widely distributed in the plant kingdom (Simonsen & Ross, 1957) . The compound is present in great abundance in the wax-like coatings of apples, pears and other fruits (Sando, 1923; Markley et al., 1935; Markley & Sando, 1937; Croteau & Fagerson, 1971) . From the data of Fernandes et al. (1964) we calculate that one mature Bramley apple, for example, may contain over 50 mg of ursolic acid in its peel. Ursolic acid has also been isolated from many medicinal plants, and has a variety of pharmacological activities attributed to it, including anti-arthritic, anti-ulcer and anti-inflammatory activities (Iwu & Ohiri 1980; Gupta et al., 1981 ; Kosuge et al., 1985; Hirota et al., 1990) . The reported anti-inflammatory activities of this compound prompted us to investigate its potential as an inhibitor of HLE. The present data demonstrate that the compound is an effective agent in protecting several synthetic peptide substrates and insoluble elastin against hydrolysis by HLE. Ursolic acid is even effective as an inhibitor of HLEmediated degradation of 3H,35S-labelled extracellular matrix (Q.-L. Ying, A. R. Rinehart, S. R. Simon & J. C. Cheronis, unpublished work). However, these 'in vitro' results do not necessarily confirm that the pharmacological effects observed in vivo can be attributed to elastase inhibition. In the published studies employing animal models, the triterpene was administrated orally (Iwu & Ohiri, 1980; Gupta et al., 1981; Kosuge et al., 1985) . Given the low solubility of ursolic acid in aqueous solution and the value of the inhibition constant, this compound may not reach a sufficiently high concentration at an inflammatory focus to inhibit the levels of HLE released by large numbers of recruited neutrophils (Bieth, 1984) . Alternative mechanisms of action may contribute to the observed pharmacological effects. Such alternative mechanisms are even more likely to account for the efficacy of oleanolic acid, hederagenin and 18fl-glycyrrhetic acid, which have also been reported to be effective antiinflammatory agents (Finney & Somers, 1958; Gupta et al., 1969; Bhargava et al., 1970; Chaturvedi et al., 1976; Takagi et al., 1980) . However, as a class of readily available natural products of limited toxicity, pentacyclic triterpenes can serve as parent compounds for a new class of HLE inhibitors with greater potency.
